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The application of probiotics in aquaculture has received concerted research efforts but the localised
intestinal immunological response of ﬁsh to probiotic bacteria is poorly understood. Therefore, a study
was conducted to evaluate the probiotic effect of Pediococcus acidilactici on Nile tilapia (Oreochromis
niloticus) with speciﬁc emphasis on intestinal health and probiotic levels as well as system level re-
sponses such as growth performance, feed utilization and haemato-immunological parameters under
non-challenged conditions. Fish (9.19  0.04 g) were fed either a control diet or a P. acidilactici sup-
plemented diet (at 2.81  106 CFU g1) for six weeks. At the end of the study the probiotic was observed
to populate the intestine, accounting for ca. 3% (1.59  105 CFU g1) of the cultivable intestinal bacterial
load. Real-time PCR indicated that the probiotic treatment may potentiate the immune-responsiveness of
the intestine as up-regulation of the gene expression of the pro-inﬂammatory cytokine TNFa was
observed in the probiotic fed ﬁsh (P < 0.05). Light microscopy observations revealed elevated intra-
epithelial leucocyte (IEL) levels in the intestine of P. acidilactici fed tilapia after six weeks (P < 0.05) of
feeding and a trend towards elevated goblet cells was also observed after six weeks feeding (P ¼ 0.08).
Concomitantly at week six, along with elevated IELs and elevated TNFa mRNA levels in the intestine, an
increased abundance of circulating neutrophils and monocytes were observed in ﬁsh fed the probiotic
supplemented diet (P < 0.05). This haemopoietic expansion of innate immune cells could be reﬂective of
an elevated state of immuno-readiness. Together these results suggest that the probiotic has a protective
action on the intestinal mucosal cells, stimulating the innate immune response after feeding for a period
of six weeks. These immunological modulations did not impair growth performance or the remaining
haematological and zootechnical parameters compared to the control group (P > 0.05).
 2013 Elsevier Ltd. All rights reserved.1. Introduction
The gut microbiome of vertebrates has been well studied over
the past decade and its functions and implications towards host
organism health, development, nutrition, disease and recently on
reproduction is becoming well documented [1e4]. The application
of feed additives, such as probiotics, to fortify these microbial
communities and subsequently provide host beneﬁts has therefore
receivedmuch attention. A number of studies have investigated the
efﬁcacy of probiotics in aquafeeds (for review see Refs. [5e7]). The
majority of these studies have looked at ﬁsh immune responses and.
(D.L. Merriﬁeld).
All rights reserved.disease resistance and, although not in all cases, improved immu-
nological responses and disease resistance have often been re-
ported [5e9]. The application of probiotics can also improve
growth, embryo and larval development [10], stress tolerance [11],
fecundity [4,12e16], gastrointestinal morphology, and microbial
balance [17e24]. These studies provide important information,
particularly at the whole organism level, but our understanding of
the mechanisms involved in mediating these responses is some-
what limited due to a paucity of information regarding the hoste
microbe interactions at the intestinal mucosal interface. This is
particularly true for tilapia (Oreochromis niloticus), which are an
important cultured ﬁsh species with global production of over 2.5
million metric tonnes in 2010, valued at over $4 billion [25]. Our
previous research has demonstrated that dietary application of the
probiotic Pediococcus acidilactici can modulate the intestinal
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out-competing certain bacterial phylotypes and reducing bacterial
diversity [8]. However, the impact of these microbial changes on
the host mucosa is poorly understood. In order to utilise probiotics
effectively it is vital to gain a clear understanding of the underlying
mechanisms at the intestinal interface which initiate and drive host
beneﬁts. Pro-inﬂammatory cytokines, including tumour necrosis
factor-a (TNFa), are often used as biomarkers for immune-
regulation. This cytokine plays an important role in orchestrating
host defence mechanisms in response to bacterial colonization or
invasion. The inﬂammatory process is a vital component of the
innate immune response and therefore the ﬁrst aim of the present
study was to assess the effect of dietary P. acidilactici on localised
intestinal immune status by assessing the expression of TNFa, the
intestinal morphology and abundance of immune cells in the tilapia
intestine. The secondary aimwas to investigate the systemic effects
on growth performance and heamato-immunological status.
2. Materials and methods
All experimental work involving ﬁsh was conducted under the
UK Home Ofﬁce project licence PPL 30/2644 and was in accordance
with the UK Animals (Scientiﬁc Procedures) Act 1986 and the Ply-
mouth University Ethical Committee.
2.1. Diet preparation
Two iso-nitrogenous and iso-lipidic diets were formulated
(Table 1) according to the known requirements for tilapia [26].
P. acidilactici MA 18/5 M (Bactocell, Lallemand Inc., Canada) was
cultured and the diets were prepared as described previously [8] to
produce 2 mm pellets. The bacterial cells were diluted to the
desired concentration based on a calibration curve (CFU ml1 vs
OD590) to achieve the manufacturer’s recommended dose in the
ﬁnal pellet (106 CFU g1). Washed cells were then added drop wise
into the basal mixture which was thoroughly homogenised, with
the addition ﬁsh oil, corn oil and warm water until a doughy con-
sistency was achieved. This was the then cold press extruded usingTable 1
Dietary formulations (%) and chemical composition.
Control Probiotic
Fishmeala 25.00 25.00
Soyabean mealb 16.09 16.09
Corn starchc 32.51 32.51
Lysamine pea proteind 10.00 10.00
Glutalysd 10.00 10.00
Sunﬂower oil 3.80 3.80
Vitaminemineral premixe 2.00 2.00
CMC-binderc 0.50 0.50
Probiotic (CFU g1)f 0.00 2.81  106
Chemical composition (%)
Dry matter 95.30 96.55
Crude proteing 44.44 43.83
Crude lipidg 6.97 7.33
Ashg 5.93 6.16
Gross energy (MJ kg1)h 19.85 19.64
a Herring meal LT92 e United Fish Products Ltd., Aberdeen, UK.
b Hamlet HP100 (57% crude protein), Hamlet Protein, Denmark.
c Sigma- Aldrich Ltd., UK.
d Roquette Frêres, France.
e Premier nutrition vitamin/mineral premix contains: 121 g kg1 calcium, Vit A
1.0 mg kg1, Vit D3 0.1 mg kg1, Vit E (as alpha tocopherol acetate) 7.0 g kg1, Copper
(as cupric sulphate) 250 mg kg1, Magnesium 15.6 g kg1, Phosphorous 5.2 g kg1.
f P. acidilactici (CNCM MA 18/5 M), Bactocell (Lallemand Inc., Canada).
g Values given are based on a dry matter basis.
h Gross energy (MJ kg1) calculated according to 23.6 kJ g1 for protein,
39.5 kJ g1 for lipid and 17.0 kJ g1 for NFE.a PTM Extruder system (model P6, Plymouth, UK) [8,20]. The same
volume of PBS (without P. acidilactici) was added to the basal
mixture for the control diet. The diets were dried to ca. 5% moisture
in an air convection oven set at 50 C and composition analysed
using AOAC [27] protocols (Table 1). Experimental diets were sub-
sequently refrigerated at 4 C and stored in airtight containers prior
to use. The probiotic inclusion levels (2.81  106 CFU g1) were
conﬁrmed by spread plating the diets on de Man, Rogosa & Sharpe
agar (MRS; Oxoid, Basingstoke, UK) for 24 h at 37 C. Sequence
analysis of 16S rRNA was undertaken to conﬁrm identiﬁcation of
P. acidilactici isolates using the primers 27F and 1491R, as described
in detail elsewhere [8].
2.2. Experimental design
Genetically male red Nile tilapia O. niloticus (GMT, Fishgen UK)
were obtained from the Institute of Aquaculture, University of Stir-
ling, UK and transported to the Aquaculture and Fish Nutrition
Research Aquarium, Plymouth University, UK where they were
allowed eight weeks of acclimation. Three hundred and twenty ﬁsh
were randomly distributed into 8  80-l tanks with four replicate
tanks per dietary treatment (40 ﬁsh per tank; average
weight ¼ 9.19  0.04 g) containing aerated recirculated freshwater.
Fish were fed experimental diets at a rate of 4% biomass per day
provided in equal rations at 09:00, 13:00 and 17:00 for six weeks.
Daily feed was adjusted on a weekly basis by batch weighing
following a 24-h starvationperiod. Fishwere held at 271 Cwith a
12: 12 h light: dark photoperiod. Water quality parameters were
monitored throughout the trial andweremaintained at 6.6 0.4 pH
(adjusted with NaHCO3 as necessary) and dissolved oxygen >80%
saturation. Ammonium, nitrite and nitrate levels were monitored
weekly and water changes (w20% system volume) were conducted
everyweek tominimise the build-up of these compounds as well as
to prevent background system build-up of probiotic levels.
2.3. Intestinal probiotic levels
At the end of the trial, six ﬁsh per experimental treatment were
sampled to enumerate the intestinal microbiota. The gastrointes-
tinal tract was aseptically removed in its entirety and allochthonous
microbial populations were isolated from the intestine as described
elsewhere [28]. Since inter-ﬁsh variation has been reported previ-
ously [29,30] the faecal matter from two ﬁsh per tank was pooled
yielding three samples per treatment. Samples were serially diluted
with PBS and 100 ml was spread onto duplicate tryptone soya agar
(TSA, Oxoid, Basingstoke, UK) plates to determine total aerobic
heterotrophic populations and MRS for LAB using the spread plate
method. MRS and TSA plates were incubated at 30 C (comparable
to tilapia culture conditions) for 48 h and colony forming units
(CFU) g1 were calculated by counting colonies from statistically
viable plates (i.e. plates containing 20e300 colonies). Sequence
analysis of 16S rRNA was undertaken on a representative subset of
LAB isolates to conﬁrm identiﬁcation of P. acidilactici.
2.4. Intestinal histology
Two ﬁsh per tank were sampled for histological appraisal of the
mid-intestine at the mid and endpoint of the trial (n ¼ 8). For light
microscopy, the tissue samples were ﬁxed in 10% formalin, dehy-
drated in graded ethanol concentrations and embedded in parafﬁn
wax. In each specimen, multiple sets of sections (5 mm thick) were
stained with May-Grünwald Giemsa (MGG), haematoxylin and
eosin (H&E) and Alcian-Blue-PAS [8,31]. The intestinal perimeter
ratio (arbitrary units; AU) was assessed [32] and the numbers of
intra epithelial leucocytes (IEL’s) and goblet cells in the epithelium,
Table 3
Viable counts (log CFU g1) of cultivable aerobic bacteria, LAB and % LAB in the
digesta of Nile tilapia after six weeks of feeding on the experimental diets (n ¼ 3).
Control Probiotic P-value
TVC 7.21  0.16 6.62  0.42 0.101
LAB 3.09  0.45a 5.20  0.41b 0.014
% LAB <0.01  0.00a 3.16  0.12b 0.010
Values with different superscripts indicate signiﬁcant differences (P < 0.05).
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cells), was then calculated by averaging the cell numbers from all
specimens [8].
Samples for transmission electron microscopy (TEM) were ﬁxed
in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at pH 7.2
and 20 C, for 1 h, and post-ﬁxed in 1.0% osmium tetroxide (OsO4) in
0.1 M sodium cacodylate buffer at pH 7.2 and 20 C, for 2 h. Samples
were then rinsed in buffer, dehydrated in ethanol, inﬁltrated in low
viscosity resin (Agar Scientiﬁc, Essex, UK), and polymerised over-
night in cofﬁn moulds at 60 C. Ultra-thin sections were stained
with a saturated uranyl acetate solution, post stainedwith Reynolds
lead citrate and examined with a Jeol JSM 1200 EX II (Tokyo, Japan)
transmission electron microscope at 120 kV.2.5. Intestinal gene expression
2.5.1. RNA extraction, cDNA synthesis and real-time PCR
Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s protocol, with some modiﬁ-
cations as previously indicated [9]. RNA concentration and purity
were measured spectrophotometrically (NanoDrop Technologies,
Wilmigton, USA) and stored at 80 C until use. Total RNA was
treated with DNAse (10 UI at 37 C for 10 min, MBI Fermentas), and
a total amount of 1 mg of RNA was used for cDNA synthesis,
employing iScript cDNA Synthesis Kit (Bio-Rad CA, USA). PCRs were
performed with the SYBR green method in an iQ5 iCycler thermal
cycler (Bio-Rad). Duplicate PCR reactions were carried out for each
sample analysed. The reactions were set on a 96-well plate by
mixing, for each sample the treatment mix was 1 mL of diluted (1/
20) cDNA, 5 mL of 2 concentrated iQ SYBR Green Supermix (Bio-
Rad), containing SYBR Green as a ﬂuorescent intercalating agent,
0.3 mMof forward primer and 0.3 mMof reverse primer. The thermal
proﬁle for all reactions was 3 min at 95 C and then 45 cycles of 20 s
at 95 C, 20 s at 60 C and 20 s at 72 C. Fluorescence monitoring
occurred at the end of each cycle. Additional dissociation curve
analysis was performed and showed in all cases one single peak. b-
actin was used as the reference gene in each sample in order to
standardize the results by eliminating variation in mRNA and cDNA
quantity and quality. The sequences of speciﬁc primers used for b-
actin and TNFa are reported in Table 2. No ampliﬁcation product
was observed in negative controls and no primeredimer forma-
tions were observed in the control templates. The data obtained
were analysed using the iQ5 optical system software version 2.0
(Bio-Rad).
2.5.2. Haemato-immunological parameters
Blood was taken from two ﬁsh per tank at the trial midpoint (i.e.
day 22) and four ﬁsh per tank at the end of the study (i.e. day 42).
Fish were anaesthetized with tricaine methanesulfate (MS222) at
150mg l1 and samples were taken from the caudal arch using a 25
gauge needle and a 1 ml syringe. Blood smears were prepared for
the determination of differential leucocyte counts whilst additional
blood was left to clot for a period of 12 h (at 4 C) to isolate serum.
Serum was isolated by centrifugation at 3600 g for 5 min and was
stored at 80 C. Haematocrit (measured and read as % packed cell
volume; PCV), haemoglobin, erythrocyte counts (RBC), serum
lysozyme activity, leucocyte counts (WBC) and differentialTable 2
Primers used for real-time PCR analyses.
Gene Forward primer Reverse prime
TNFa GGTCATCTGGAGTGGAGGAA AGCCGTGGTCT
b-Actin GTGCCCATCTACGAGGGTTA CTCCTTAATGTleucocyte proportions were determined according to standard
methods described elsewhere [33].
2.5.3. Growth performance and zootechnical parameters
Growth performance and feed utilisation were assessed by net
weight gain (NWG), speciﬁc growth rate (SGR), feed conversion ratio
(FCR), protein efﬁciency ratio (PER) and condition factor (K). Calcu-
lations were carried out using the formulae: SGR ¼ 100 ((ln FWe
ln IW)/T); FCR ¼ FI/WG; PER ¼ WG/PI and K ¼ (100  FW)/(FL3),
where FW¼ ﬁnal weight (g), IW¼ initial weight (g), T¼ duration of
feeding (days), WG ¼ wet weight gain (g), FI ¼ feed intake (g),
PI¼ protein ingested and FL ¼ ﬁnal length (cm). At the beginning of
the trial, 30 ﬁsh were pooled to make three samples to determine
initial carcass compositionandat the endof the trial fourﬁshper tank
were sampled to determine ﬁnal carcass composition. Proximate
composition analysis was conducted according to AOAC protocols
[27].
At the end of the trial four ﬁsh per tank were euthanized with
tricaine methanesulfate (MS222) at 200 mg l1 followed by
destruction of the brain. These ﬁsh were used to record viscera
weight and whole body weight in order to calculate the hep-
atosomatic index (HSI) and viscerosomatic index (VSI). Calculations
were made using the following formulae: HSI ¼ (LW/BW)  100
and VSI ¼ (VW/BW)  100. Where LW ¼ liver weight (g),
BW ¼ body weight (g) and VW ¼ viscera weight (g).
2.5.4. Statistical analysis
All data are presented as mean  standard deviation (SD). All
data were checked for normality using a KolmogoroveSmirnov test
and analysed using a t-test (SPSS Inc., 15.0, Chicago, IL, USA). In all
cases signiﬁcance was accepted at P < 0.05.
3. Results
3.1. Intestinal probiotic levels
Bacterial levels within the digesta of ﬁsh fed experimental diets
are displayed in Table 3. Allochthonous total cultivable levels (TVC)
were not affected by the probiotic treatment (P ¼ 0.101), however,
compared to ﬁsh fed the control diet, LAB levels were signiﬁcantly
(P ¼ 0.014) higher in the probiotic fed ﬁsh. LAB isolated from the
probiotic fed ﬁsh were identiﬁed as P. acidilactici by 16S rRNA
sequence analysis.
3.2. Intestinal histology
Light microscopy revealed that the intestine of tilapia fed either
a control or probiotic supplemented diet showed an intactr Amplicon size Genbank number
GAGAAGCTA 295 AY428948.1
CACGAACGA 156 EU887951.1
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mucosal folds. The intestinal mucosa consisted of a simple
epithelium and a lamina propria (LP) which housed scattered IELs
together with acidophilic granulocytes (AGs) (Fig. 1) both in the
control and probiotic group. The number of IELs residing between
every 100 enterocytes in the intestine of the probiotic fed ﬁsh was
signiﬁcantly (P ¼ 0.039) elevated at six weeks (140.80  11.94 vs
114.60  16.85 in the control) but did not differ at three weeks
(Fig. 2A). The number of goblet cells remained unaffected at weekFig. 1. Light (AeF) and electron (G and H) micrographs of the mid-intestine of Nile tilapia
experimental period. Note that the goblet cells are ﬁlled with abundant acidic mucins in both
acidophilic granulocytes (stained pink) are scattered amongst the mucosa (arrows). Electr
elongated cuboidal enterocytes and tight junctional complexes. Abbreviations used are E: e
junctions. Light microscopy staining: A, B: H&E; C, D: MGG; E, F: Alcian-Blue-PAS. Scale bathree but a trend towards elevation (P¼ 0.080) was observed in the
probiotic fed ﬁsh at week six (Fig. 2B). Alcian-Blue PAS stained
sections revealed that the goblet cells of the GI tract (both treat-
ments and both timepoints) were ﬁlled with abundant acidic mu-
cins which were also present lining the epithelium forming a
mucus barrier, in both treatments (Fig. 1E and F). The perimeter
ratio (a higher perimeter ratio indicates a higher absorptive intes-
tinal surface area brought about by more numerous and/or longer
mucosal folds) of the intestine in the control group (weekfed either the control (A, C, E and G) or probiotic (B, D, F and H) diet at the end of the
treatments. Abundant IELs are present in the epithelia and a distinct sub-population of
on micrographs show the apical brushborder revealing intact epithelia comprised of
pithelia; GO: goblet cells; LP: lamina propria, L: lumen, MV: microvilli and TJ ¼ tight
rs ¼ 50 mm (AeF), 2 mm (G and H).
Fig. 2. (A) IEL abundance (per 100 enterocytes), (B) goblet cell abundance (per 100
enterocytes) and (C) TNFa mRNA levels (AU; normalized against b-actin) in the tilapia
mid-intestine fed either a control or a probiotic supplemented diet for three and six
weeks. Data are given as mean values  SD (n ¼ 8). *, ** and *** denote differences
between the treatment groups at the P < 0.01, P < 0.05 and P < 0.10 level, respectively.
Table 4
Haematological and immunological parameters of Nile tilapia after six weeks of
feeding on the experimental diets. n ¼ 16.
Control Probiotic P-value
Haematocrit (%PCV) 30.10  7.74 29.44  3.20 0.899
Haemoglobin (g dl1) 5.66  1.01 7.15  1.67 0.256
RBC (106 ml1) 1.26  0.39 1.25  0.25 0.962
WBC (103 ml1) 14.33  3.73 16.70  8.38 0.633
MCV (fL) 245.49  42.68 247.88  62.70 0.959
MCH (pg) 47.85  11.57 56.94  3.16 0.281
MCHC (g dl1) 20.16  5.91 24.78  7.23 0.430
Serum lysozyme 178.50  73.05 189.68  69.20 0.774
RBC ¼ red blood cells.
WBC ¼ leucocytes.
MCV ¼ mean corpuscular volume ¼ (haematocrit (%PCV)  10)/RBC (106 ml1).
MCH ¼ mean corpuscular haemoglobin ¼ (haemoglobin (g dl1)  10)/RBC
(106 ml1).
MCHC ¼ mean corpuscular haemoglobin concentration ¼ (haemoglobin
(g dl1)  100)/haematocrit (%PCV).
Table 5
Circulatory leucocyte proportions of Nile tilapia at the midpoint (week three) and
end of the trial (week six).
Leucocyte type (%) Control Probiotic P-value
Week threea
Lymphocytes 68.25  5.50 66.00  13.00 0.662
Neutrophils 19.25  9.88 24.10  12.30 0.397
Monocytes nd nd
Thrombocytes 12.40  12.20 9.90  11.30 0.678
Week sixb
Lymphocytes 83.44  9.38 81.19  8.20 0.476
Neutrophils 8.25  5.60A 12.94  6.95B 0.045
Monocytes 0.13  0.34A 1.69  2.06B 0.009
Thrombocytes 8.19  7.84 4.19  4.61 0.091
AB Values with different superscripts indicate signiﬁcant differences (P < 0.05).
nd ¼ not detected (below detection threshold).
a n ¼ 8.
b n ¼ 16.
B.T. Standen et al. / Fish & Shellﬁsh Immunology 35 (2013) 1097e1104 1101three ¼ 4.11  0.71 AU and week six ¼ 3.64  0.43 AU) did not
signiﬁcantly differ to that of the probiotic fed ﬁsh at week three
(4.66 0.78 AU) or week six (3.991.18 AU). Transmission electron
microscopy observation of the apical brushborder revealed intact
epithelia in both treatments; elongated cuboidal enterocytes were
bound together by tight junctional complexes and signs of endo-
cytic activity were observed with pinocytosis occurring between
and beneath the microvilli. Below the brush border a high level of
mitochondria were present. There were no signs of damage in
either dietary treatment (Fig. 1G and H). Densely packed microvilliwere present on the enterocyte surfaces and the microvilli height
did not differ between treatments (1.61  0.05 mm and
1.62  0.57 mm for the control and probiotic groups, respectively).
3.3. Intestinal TNFa gene expression
The expression of the pro-inﬂammatory cytokine TNFa in the
mid-intestine of tilapia is displayed in Fig. 2C. TNFa expression was
signiﬁcantly up-regulated in the probiotic group at week three
(P ¼ 0.042) and week six (P ¼ 0.005) compared to the control ﬁsh
(Fig. 2C).
3.4. Haemato-immunological parameters
Haematological and immunological parameters are displayed in
Tables 4 and 5. Haematocrit levels remained unaffected by the
probiotic treatment (PCV ¼ w30% in both groups), as did haemo-
globin levels (w6 g dl1). There were no signiﬁcant differences
between total numbers of erythrocytes (RBC), mean corpuscular
volume (MCV), mean corpuscular haemoglobin (MCH) and mean
corpuscular haemoglobin concentration (MCHC) between dietary
groups (P > 0.05). Additionally, there were no signiﬁcant differ-
ences of serum lysozyme activity between the two dietary treat-
ments. Although there were no signiﬁcant differences between
total numbers of circulatory leucocytes (WBC), the proportions of
leucocyte types was signiﬁcantly altered in the probiotic fed ﬁsh at
week six (Table 5). At week six ﬁsh fed P. acidilactici displayed
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(P < 0.01) and a trend towards a signiﬁcantly lower proportion of
thrombocytes (P ¼ 0.091). These differences were not observed at
week three.
3.5. Growth performance and zootechnical parameters
Growth performance, feed utilisation and somatic indices are
displayed in Table 6. Both dietary groups grew very well with
>250% increase in body weight after six weeks feeding. There were
no signiﬁcant differences (P > 0.05) between the groups with
respect to growth, feed utilisation, hepatosomatic index (HSI),
viscerosomatic index (VSI), condition factor or survival. Addition-
ally, body composition was also unaffected (data not shown).
4. Discussion
In the present study dietary P. acidilactici provision led to high
populations of P. acidilactici (1.59  105 CFU g1) in the intestine
which is in the same range reported in previous studies using this
probiotic in tilapia [8], rainbow trout [28,34] and shrimp [35]. Our
previous studies, using both culture-dependent and culture-
independent methodology, indicate that this probiotic is able to
survive gastric passage, populate the intestinal tract, out-compete
some endogenous phylotypes and form associations with the
tilapia intestinal mucosa [8]. These are important criteria for a
probiotic candidate and it is essential that probiotic candidates
survive gastric passage in high numbers in order to exert their ef-
fect at the site of action, the intestine.
The present study shows that the functionality of the tilapia
immune system, at the local level, was inﬂuenced by signals from
the de novo probiotic colonizers, or transient probiotic bacteria,
administered. This study revealed the effect of feeding probiotic
supplemented diets on the expression of the pro-inﬂammatory
cytokine TNFa, which is commonly used as a biomarker for
immune-regulation. TNFa contributes to the defence mechanisms
of the host in response to bacterial colonization, or invasion, by
inducing an inﬂammatory response which acts to recruit more
lymphoid cells to the site of colonisation/infection. The cellular
response in the tilapia intestine in the present study, increased
TNFa production, implies that probiotic fed ﬁsh are in an immu-
nologically elevated state which may aid in resisting pathogenic
insults by improving the immune-readiness. These ﬁndings are in
agreement with previous studies that have shown that the sup-
plementation of probiotic bacteria increases the expression of pro-
inﬂammatory cytokines, including IL-1b and TNFa in ﬁsh [9,36,37].
In mammals, previous studies have evidenced that cell surveillanceTable 6
Growth performance and zootechnical parameters of Nile tilapia after six weeks of
feeding on the experimental diets. n ¼ 4.
Parameters Control Probiotic P-value
Initial body weight (g ﬁsh1) 9.19  0.05 9.19  0.03 1.000
Final body weight (g ﬁsh1) 33.77  1.04 34.50  1.51 0.459
Weight gain (g ﬁsh1) 24.57  1.06 25.31  1.48 0.456
Speciﬁc growth rate (% day1) 3.55  0.07 3.59  0.12 0.655
Feed conversion ratio (g g1) 0.99  0.03 0.98  0.04 0.857
Mean daily feed intake
(g ﬁsh1 day1)
0.97  0.03 0.96  0.03 0.620
Condition factor (K)a 1.74  0.07 1.71  0.12 0.642
Apparent protein utilisation (%) 27.53  6.35 33.97  3.06 0.142
Protein efﬁciency ratio (PER) 1.66  0.06 1.71  0.10 0.470
VSI (%)a 10.48  0.53 10.27  0.30 0.537
HSI (%)a 1.53  0.18 1.84  0.17 0.056
Survival (%) 96.05  3.40 98.68  1.52 0.230
a n ¼ 16.of gut microbiota is routinely exerted by the gastrointestinal im-
mune system [38] and regulatory signals generated by probiotics
may be able to stimulate host immunity to afford a degree of
enhanced protection against pathogens [39].
TNFa is an acute phase protein which initiates a cascade of cy-
tokines which subsequently recruits macrophages and neutrophils
to the site of inﬂammation. It would be tempting to suppose
therefore that the elevated IELs observed in the intestine of the
probiotic fed ﬁsh at week six were likely to be macrophages and
neutrophils but from the methods used in the present investigation
it is not possible to accurately quantify the leucocyte sub-
populations in the epithelium. The increase in monocytes and
neutrophil proportions in the blood, combined with an increased
expression of TNFa supports the stimulation of the innate immune
response in ﬁsh fed the probiotic. MGG staining revealed that acidic
granulocytes were present in the epithelium. These ﬁndings are
consistent with previous studies which revealed elevated IELs
(speciﬁcally acidic granulocytes, T cells and Igþ cells) in the intes-
tine of gilthead sea bream and European sea bass fed dietary
Lactobacillus spp. [40,41]. In the present study elevated goblet cell
levels were also present at week six in the probiotic group. Alcian-
Blue PAS stained micrographs showed that goblet cells residing in
the GI tract of ﬁsh fed either dietary treatment were ﬁlled with
abundant acidic mucins. This was also evident in the mucus layer
lining the epithelia. This viscous barrier helps prevent pathogenic
invasion by trapping and enabling the removal of potentially
harmful antigenic material as well as containingmany antibacterial
substances providing protection [42]. The gastrointestinal tract of
ﬁsh is a portal of entry for a number of important ﬁsh pathogens
[43] and elevated IELs and goblet cell levels may therefore provide
an elevated resistance to intestinal pathogenesis. Our previous
studies using this probiotic in rainbow trout experiments have also
revealed elevated goblet cells and IELs in the intestine and this
appeared to lead to a qualitative reduction in the extent of
epithelial damage induced by V. anguillarum in ex vivo intestinal sac
experiments [44]. In the present study there was no signiﬁcant
difference in perimeter ratio between dietary treatments after
three weeks (P ¼ 0.603) or six weeks (P ¼ 0.726). Transmission
electron microscopy of the intestine of ﬁsh fed P. acidilactici
revealed no signs of histological damage and the epithelium con-
formed to healthy morphology as observed in the control group;
the apical brushborder exhibited a typical structure composed of
uniformly formed microvilli structures with epithelial integrity
maintained by tight junctions between enterocytes.
Despite changes in the localised immune status there was
little effect on the systemic immune parameters investigated.
P. acidilactici has previously been reported to positively inﬂuence
tilapia immunity by enhancing circulatory leucocyte numbers and
increasing serum lysozyme activity [8]. However, contradictory re-
sults are present in the literature regarding the response of serum
lysozyme activity and circulatory leucocyte levels in probiotic fed
ﬁsh [22,28,45]. These differences may be attributed to the different
ﬁsh species, stage of development, strain of probiotic, dosage,
duration of feeding, feed composition, mode of supplementation
and/or environmental/rearing conditions. In the present study
changes in the proportions of leucocytes were observed as mono-
cytes and neutrophils proportions were signiﬁcantly elevated at
week six in the probiotic fed ﬁsh. Monocytes and neutrophils are
key components of the innate immune response; neutrophils are
one of the ﬁrst cells to respond to inﬂammation andmonocytes also
react quickly to replenish macrophage and dendritic populations at
inﬂammatory sites [46]. Their elevation in the bloodstream is
indicative of a potentiated systemic response, which may provide a
more rapid non-speciﬁc immune response upon pathogenic
infection.
B.T. Standen et al. / Fish & Shellﬁsh Immunology 35 (2013) 1097e1104 1103Fish grew well with >250% increase in biomass and >95% sur-
vival in all treatments. The growth performance, feed utilisation,
body composition, somatic indices and haematological parameters
were not affected by dietary treatment. This is perhaps not sur-
prising given that the ﬁsh were subjected to good environmental
conditions (e.g. water quality, temperature dissolved oxygen etc.),
high husbandry care and were provided with a highly nutritive
value diet meeting, or exceeding, the known requirements of tilapia
[19]. However, it is important to note that despite the elevated
immunological responses observed, the probiotic fed ﬁsh main-
tained high growth performance in line with that of the control
group.
The present study suggests therefore that P. acidilactici modu-
lates both localised intestinal- and peripheral- innate immunity in
tilapia without detrimental effects on the intestinal morphology,
haematological parameters or growth performance. Future studies
should assess disease resistance, against enteropathogens in
particular, to determine the degree of beneﬁt afforded by these
elevated immunological responses.
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